Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. It works by blocking the reverse transcriptase enzyme, preventing the virus from replicating in the body. Abacavir is often prescribed in combination with other antiretroviral drugs to effectively manage HIV infection and reduce viral load, helping patients achieve long-term viral suppression.
With the rising demand for effective and affordable antiretroviral therapy, selecting a reliable Abacavir manufacturer is crucial. Leading manufacturers adhere to WHO-GMP, USFDA, and EU-GMP standards to ensure the production of high-quality, safe, and effective formulations. These manufacturers invest in advanced pharmaceutical technologies to enhance the drug’s bioavailability and therapeutic efficacy.